Home » Topics » BioWorld Science

BioWorld Science
RSS

Sorrento cleared to begin phase II study in U.S. with abivertinib for COVID-19

July 21, 2020

Phase III CLARITY study of pimavanserin in MDD does not meet primary endpoint

July 21, 2020

FDA clears IND for phase II study of NT-I7 with nivolumab in gastric cancers

July 21, 2020

Phase III study of Trikafta in cystic fibrosis meets primary and secondary endpoints

July 21, 2020

Three COVID-19 vaccines generate T-cell responses

July 21, 2020

Hillstream Biopharma presents preclinical data for HSB-1216 in cancer

July 21, 2020

SERENITY I and SERENITY II pivotal studies meet primary and secondary endpoints

July 21, 2020

First-in-human study of anticoagulant ONO-7684 successful in healthy subjects

July 21, 2020

Positive interim efficacy and safety data presented for BNZ-1

July 21, 2020

First patient dosed in pivotal phase II portion of LOTIS 3 study

July 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...